Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Dyer

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Seminars in Oncology|November 24, 1999
The role of CAMPATH-1 antibodies in the treatment of lymphoid malignanciesM J Dyer
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
PML/RAR alpha + ATRA = CR. A comment on acute promyelocytic leukaemia: molecular pathology and treatmentM J Dyer
Cancer Treatment and Research|January 1, 1993
Chimeric antibodies for the treatment of hematologic malignancyM J Dyer
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Antibody therapy of malignancyM J Dyer
Blood|August 15, 1989
T-cell receptor delta/alpha rearrangements in lymphoid neoplasmsM J Dyer
Genes, Chromosomes & Cancer|December 1, 1993
Unusual deletions in the immunoglobulin heavy chain locus in follicular B-cell lymphoma with t(14;18)(q32.3;q21.3)M J Dyer
British Journal of Cancer|July 17, 1999
Bcl10 mutations in malignancyM J Dyer
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
The new genetics and non-Hodgkin lymphomaM J Dyer
National Journal|May 14, 1996
A health care lobbyist to the bone. Interview by Marilyn Werber SerafiniM J Dyer
Critical Reviews in Eukaryotic Gene Expression|June 18, 2002
Proteolytic cleavage of molecules involved in cell death or survival pathways: a role in the control of apoptosis?L Karran, M J Dyer
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Seminars in Oncology|November 24, 1999
The role of CAMPATH-1 antibodies in the treatment of lymphoid malignanciesM J Dyer
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
PML/RAR alpha + ATRA = CR. A comment on acute promyelocytic leukaemia: molecular pathology and treatmentM J Dyer
Cancer Treatment and Research|January 1, 1993
Chimeric antibodies for the treatment of hematologic malignancyM J Dyer
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Antibody therapy of malignancyM J Dyer
Blood|August 15, 1989
T-cell receptor delta/alpha rearrangements in lymphoid neoplasmsM J Dyer
Genes, Chromosomes & Cancer|December 1, 1993
Unusual deletions in the immunoglobulin heavy chain locus in follicular B-cell lymphoma with t(14;18)(q32.3;q21.3)M J Dyer
British Journal of Cancer|July 17, 1999
Bcl10 mutations in malignancyM J Dyer
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
The new genetics and non-Hodgkin lymphomaM J Dyer
National Journal|May 14, 1996
A health care lobbyist to the bone. Interview by Marilyn Werber SerafiniM J Dyer
Critical Reviews in Eukaryotic Gene Expression|June 18, 2002
Proteolytic cleavage of molecules involved in cell death or survival pathways: a role in the control of apoptosis?L Karran, M J Dyer
Pageof 9